Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
237 participants
OBSERVATIONAL
2023-05-08
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Every 3 to 4 months, the participants' facial skin microbiota samples will be taken, and they will be asked to complete a survey.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China
NCT05638269
Characterization of the Microbiome in Cutaneous T Cell Lymphoma
NCT03932279
Influence of Nutritional Indices on the Prognosis of Patients With SARS-CoV-2 Infection
NCT05835102
Gut Microbiome and Metabolic Pathways Changes in Vitiligo
NCT03797417
Gut Microbiota in Adults With Chronic Widespread Pain
NCT05678387
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* recent medical treatment (topical antibiotics, corticosteroids, and other anti-inflammatory drugs within 4 weeks, and systemic antibiotics, corticosteroids, and other immunosuppressive drugs within 6 months)
10 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Westlake University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Westlake University
Hangzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20230103TL001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.